These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36801791)

  • 1. Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses.
    Del Rosario García-Lozano M; Dragoni F; Gallego P; Mazzotta S; López-Gómez A; Boccuto A; Martínez-Cortés C; Rodríguez-Martínez A; Pérez-Sánchez H; Manuel Vega-Pérez J; Antonio Del Campo J; Vicenti I; Vega-Holm M; Iglesias-Guerra F
    Bioorg Chem; 2023 Apr; 133():106408. PubMed ID: 36801791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy
    Celegato M; Sturlese M; Vasconcelos Costa V; Trevisan M; Lallo Dias AS; Souza Passos IB; Queiroz-Junior CM; Messa L; Favaro A; Moro S; Teixeira MM; Loregian A; Mercorelli B
    mBio; 2023 Feb; 14(1):e0309722. PubMed ID: 36622141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.
    Zephyr J; Rao DN; Johnson C; Shaqra AM; Nalivaika EA; Jordan A; Kurt Yilmaz N; Ali A; Schiffer CA
    Bioorg Chem; 2023 Feb; 131():106269. PubMed ID: 36446201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.
    Starvaggi J; Previti S; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.
    Mirza MU; Alanko I; Vanmeert M; Muzzarelli KM; Salo-Ahen OMH; Abdullah I; Kovari IA; Claes S; De Jonghe S; Schols D; Schinazi RF; Kovari LC; Trant JF; Ahmad S; Froeyen M
    Eur J Pharm Sci; 2022 Aug; 175():106220. PubMed ID: 35618201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Montelukast as flavivirus NS2B-NS3 protease inhibitor by inverse virtual screening and experimental validation.
    Jiang H; Zhang Y; Wu Y; Cheng J; Feng S; Wang J; Wang X; Cheng M
    Biochem Biophys Res Commun; 2022 May; 606():87-93. PubMed ID: 35339757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through
    Yadav R; Selvaraj C; Aarthy M; Kumar P; Kumar A; Singh SK; Giri R
    J Biomol Struct Dyn; 2021 Jan; 39(1):272-284. PubMed ID: 31920173
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Cruz-Arreola O; Orduña-Diaz A; Domínguez F; Reyes-Leyva J; Vallejo-Ruiz V; Domínguez-Ramírez L; Santos-López G
    PeerJ; 2022; 10():e13650. PubMed ID: 35945938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
    Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
    Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases.
    Millies B; von Hammerstein F; Gellert A; Hammerschmidt S; Barthels F; Göppel U; Immerheiser M; Elgner F; Jung N; Basic M; Kersten C; Kiefer W; Bodem J; Hildt E; Windbergs M; Hellmich UA; Schirmeister T
    J Med Chem; 2019 Dec; 62(24):11359-11382. PubMed ID: 31769670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Throughput Screening Targeting the Dengue NS3-NS5 Interface Identifies Antivirals against Dengue, Zika and West Nile Viruses.
    Yang SNY; Maher B; Wang C; Wagstaff KM; Fraser JE; Jans DA
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
    Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
    Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
    Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
    J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
    Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
    Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika.
    Mottin M; de Paula Sousa BK; de Moraes Roso Mesquita NC; de Oliveira KIZ; Noske GD; Sartori GR; de Oliveira Albuquerque A; Urbina F; Puhl AC; Moreira-Filho JT; Souza GE; Guido RVC; Muratov E; Neves BJ; Martins da Silva JH; Clark AE; Siqueira-Neto JL; Perryman AL; Oliva G; Ekins S; Andrade CH
    J Chem Inf Model; 2022 Dec; 62(24):6825-6843. PubMed ID: 36239304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Bispecific Lead Compounds from
    Kumar S; El-Kafrawy SA; Bharadwaj S; Maitra SS; Alandijany TA; Faizo AA; Khateb AM; Dwivedi VD; Azhar EI
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Interactions of Post Cleaved NS2B Cofactor and NS3 Protease Identified by Integrative Structural Approaches.
    Quek JP; Ser Z; Chew BLA; Li X; Wang L; Sobota RM; Luo D; Phoo WW
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
    Colarusso S; Ferrigno F; Ponzi S; Pavone F; Conte I; Abate L; Beghetto E; Missineo A; Amaudrut J; Bresciani A; Paonessa G; Tomei L; Montalbetti C; Bianchi E; Toniatti C; Ontoria JM
    Bioorg Med Chem; 2022 Mar; 57():116631. PubMed ID: 35123179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
    J Virol; 2017 May; 91(10):. PubMed ID: 28298600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.